To read the full story
Related Article
- Sawai Group President Says US Biz Exit was Due to Lack of Foresight
February 19, 2024
- Sawai Gets FDA Nod for Livalo Generic
February 13, 2017
- Sawai, Kowa/Nissan Chemical Settle US Patent Suit over Livalo
February 3, 2017
- Nissan Chemical Files Livalo Patent Suit against Sawai in US
July 31, 2014
- Sawai Seeks US Approval for Livalo Generic, Submits ANDA
June 17, 2014
BUSINESS
- Toho Launches Specialty Drug Home Delivery Service with Vyvdura
May 13, 2025
- Bayer Files Eylea 8 mg for Macular Edema following RVO in Japan
May 13, 2025
- Lusefi Filed for Pediatric Use in Japan: Taisho
May 13, 2025
- J&J Taps Chris Rieger to Lead Japan Pharma Business
May 13, 2025
- Shionogi, Cilcare Ink Research Collab on Novel Hearing Loss Drugs
May 12, 2025
The traditional HR Business Partner (HRBP) model, once the gold standard for HR delivery, is undergoing a significant transformation. Many organizations, particularly in industries like pharmaceuticals, are moving towards a more agile resource model, aiming to streamline HR operations and…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…